Summer Benefits Camp: Options for High-Value Prescription Drug Coverage

Published: June 16, 2020

Participants will:
• Understand how a fair price for prescription drugs can be determined using a value assessment framework and cost-effectiveness analysis.
• Discover two to three prescription drugs with prices in line with their clinical benefit for patients, and two to three prescription drugs with prices out of line with their clinical benefit for patients.
• Encounter three to five ways payers, employers and policymakers can use independent assessment of fair pricing to improve the value of their prescription drug spend.

Author(s)/Presenter(s):

Sarah Emond, MPP, Executive Vice President and Chief Operating Officer

Company:

Institute for Clinical and Economic Review

View All Resources